Cresco Labs (OTCMKTS:CRLBF – Get Rating) had its price target decreased by research analysts at Stifel Nicolaus from C$8.00 to C$5.00 in a research report issued to clients and investors on Thursday, The Fly reports.
Several other analysts have also recently commented on CRLBF. Piper Sandler decreased their target price on Cresco Labs from $14.00 to $9.00 and set an “overweight” rating on the stock in a report on Thursday, March 24th. Atb Cap Markets restated an “outperform” rating on shares of Cresco Labs in a research note on Wednesday, March 23rd. Canaccord Genuity Group dropped their price objective on Cresco Labs from C$15.00 to C$12.00 in a report on Friday, March 25th. Alliance Global Partners reduced their price objective on Cresco Labs from C$19.00 to C$15.00 in a research report on Thursday. Finally, Zacks Investment Research lowered Cresco Labs from a “hold” rating to a “sell” rating in a research report on Monday, May 9th. One research analyst has rated the stock with a sell rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat, Cresco Labs presently has a consensus rating of “Buy” and an average target price of $17.14.
Shares of OTCMKTS CRLBF traded down $0.04 during trading hours on Thursday, hitting $3.86. The stock had a trading volume of 554,138 shares, compared to its average volume of 550,307. The firm’s 50-day moving average price is $5.27 and its two-hundred day moving average price is $6.56. Cresco Labs has a 52 week low of $3.80 and a 52 week high of $12.88.
Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand, as well as cannabis products under the Reserve brand.
- Get a free copy of the StockNews.com research report on Cresco Labs (CRLBF)
- Don’t Bet On Cheaper Oil, Not Yet Anway
- Can Nvidia Bounce Back
- A Reversal In The S&P 500 Is Confirmed
- MarketBeat Podcast: Options Trading As Easy As Trading Stocks
- The TJX Companies: It’s Not All Doom And Gloom In Retail
Receive News & Ratings for Cresco Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cresco Labs and related companies with MarketBeat.com's FREE daily email newsletter.